Home
Doc Generici s.r.l.

Doc Generici s.r.l. Market Share Analysis for May 2026

Leader italiano nell'industria farmaceutica. Grazie ad una filiera di qualità, made in Italy, commercializziamo farmaci accessibili a tutti.

Health > Health - Other

Domaindocgenerici.it

Year Founded1996

Employees201 - 500

Annual Revenue$100M - $200M

Doc Generici s.r.l.

Doc Generici s.r.l. (including company regionals)

docgenerici.it

See more website traffic and engagement information

Doc Generici s.r.l. Revenue up to May 2026 is 100M - 200M

revenue generated by Doc Generici s.r.l. top domains

Doc Generici s.r.l. top domains revenue over 3 years

Revenue for Doc Generici s.r.l. top domains

docgenerici.it100M - 200M

See more with Sales Intelligence

Total visits to Doc Generici s.r.l.'s top domains

Understand Doc Generici s.r.l. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Doc Generici s.r.l.'s top domains

Analyze Doc Generici s.r.l. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Doc Generici s.r.l.'s top domains

See how Doc Generici s.r.l. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Doc Generici s.r.l. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

equivalente.itCompany NameFarmaci EquivalentiEmployees51 - 200HQItalyAnnual revenue$5M - $10MTotal visits74.5KHealth > Health - Other

Top technologies used by Doc Generici s.r.l.

These are the website technologies, by industry, used by Doc Generici s.r.l. top domains

Advertising (7)

DoubleClick

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

Audio Video Media (2)

YouTube

More Technologies

11

See all

News & Signals from Doc Generici s.r.l.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDoc Generici S.R.L. hires Ravi Umarji as Board of Directors.As part of the transaction, Karthic Jayaraman, Partner at TPG Capital, and TPG Capital Principal Ravi Umarji will join DOC Generici’s Board of Directors.

NewsTPG Partners acquires Doc Generici S.R.L..TPG Partners acquires DOC Generici.

NewsIntermediate Capital Group acquires Doc Generici S.R.L. for $1.2B.British buyout firm Intermediate Capital Group Plc is nearing a deal to buy Italian generic drugmaker Doc Generici from CVC Capital Partners for about 1.1 billion euros ($1.2 billion), according to people familiar with the matter.